Antibodies  	Antibodies  	 NNS	B-NP
as  	as  	 IN	O
an  	an  	 DT	O
unlimited  	unlimited  	 JJ	O
source  	source  	 NN	O
of  	of  	 IN	O
anti-infective 	anti-infective 	 NNP	B-NP
,  	,  	 ,	O
anti-tumour  	anti-tumour  	 JJ	B-NP
and  	and  	 CC	O
immunomodulatory  	immunomodulatory  	 FW	B-NP
peptides  	peptides  	 FW	I-NP
Antibodies  	Antibodies  	 FW	I-NP
( 	( 	 -LRB-	O
Abs 	Abs 	 NNP	B-NP
)  	)  	 -RRB-	O
are  	are  	 VBP	O
emerging  	emerging  	 VBG	O
as  	as  	 IN	O
an  	an  	 DT	O
important  	important  	 JJ	O
class  	class  	 NN	O
of  	of  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
various  	various  	 JJ	O
human  	human  	 JJ	O
diseases 	diseases 	 NNS	O
,  	,  	 ,	O
often  	often  	 RB	O
conjugated  	conjugated  	 VBN	O
to  	to  	 TO	O
drugs  	drugs  	 NNS	O
or  	or  	 CC	O
toxic  	toxic  	 JJ	B-NP
substances 	substances 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
recent  	recent  	 JJ	O
years 	years 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
incidence  	incidence  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
infectious  	infectious  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
has  	has  	 VBZ	O
increased  	increased  	 VBN	O
dramatically  	dramatically  	 RB	O
making  	making  	 VBG	O
it  	it  	 PRP	O
imperative  	imperative  	 VBP	O
to  	to  	 TO	O
discover  	discover  	 VB	O
new  	new  	 JJ	O
effective  	effective  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
molecules 	molecules 	 NNS	I-NP
.  	.  	 .	O
Among  	Among  	 IN	O
these 	these 	 DT	O
,  	,  	 ,	O
small  	small  	 JJ	O
peptides  	peptides  	 NNS	B-NP
are  	are  	 VBP	O
arousing  	arousing  	 VBG	O
great  	great  	 JJ	O
interest 	interest 	 NN	O
.  	.  	 .	O
Synthetic  	Synthetic  	 JJ	B-NP
peptides 	peptides 	 NN	I-NP
,  	,  	 ,	O
representative  	representative  	 NN	B-NP
of  	of  	 IN	O
variable  	variable  	 NN	O
and  	and  	 CC	O
constant  	constant  	 JJ	O
region  	region  	 NN	O
fragments  	fragments  	 NNS	O
of  	of  	 IN	O
Abs 	Abs 	 NNP	B-NP
,  	,  	 ,	O
were  	were  	 VBD	O
proved  	proved  	 VBN	O
to  	to  	 TO	O
exert  	exert  	 VB	O
in  	in  	 IN	O
vitro 	vitro 	 NN	B-NP
,  	,  	 ,	O
ex  	ex  	 FW	B-NP
vivo  	vivo  	 FW	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
anti-microbial 	anti-microbial 	 NN	I-NP
,  	,  	 ,	O
anti-viral 	anti-viral 	 NNP	B-NP
,  	,  	 ,	O
anti-tumour  	anti-tumour  	 JJ	B-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
immunomodulatory  	immunomodulatory  	 JJ	B-NP
activities 	activities 	 NNS	I-NP
,  	,  	 ,	O
mediated  	mediated  	 VBG	O
by  	by  	 IN	O
different  	different  	 JJ	O
mechanisms  	mechanisms  	 NNS	O
of  	of  	 IN	O
action  	action  	 NN	O
and  	and  	 CC	O
regardless  	regardless  	 RB	O
of  	of  	 IN	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
and  	and  	 CC	O
isotype  	isotype  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
Ab 	Ab 	 NNP	I-NP
.  	.  	 .	O
Some  	Some  	 DT	O
of  	of  	 IN	O
these  	these  	 DT	O
synthetic  	synthetic  	 JJ	B-NP
peptides  	peptides  	 NNS	I-NP
possess  	possess  	 VBP	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
spontaneously  	spontaneously  	 VB	O
and  	and  	 CC	O
reversibly  	reversibly  	 JJ	B-NP
self-assemble  	self-assemble  	 NN	I-NP
in  	in  	 IN	O
an  	an  	 DT	O
organised  	organised  	 JJ	B-NP
network  	network  	 NN	I-NP
of  	of  	 IN	I-NP
fibril-like  	fibril-like  	 JJ	I-NP
structure 	structure 	 NN	I-NP
.  	.  	 .	O
Ab  	Ab  	 NNP	B-NP
fragments  	fragments  	 NNS	I-NP
may  	may  	 MD	O
represent  	represent  	 VB	O
a  	a  	 DT	O
novel  	novel  	 NN	O
model  	model  	 NN	O
of  	of  	 IN	O
targeted  	targeted  	 JJ	O
anti-infective  	anti-infective  	 JJ	B-NP
and  	and  	 CC	O
anti-tumour  	anti-tumour  	 JJ	B-NP
auto-delivering  	auto-delivering  	 JJ	O
drugs 	drugs 	 NNS	O
.  	.  	 .	O
